Logo image of SIBN

SI-BONE INC (SIBN) Stock Fundamental Analysis

NASDAQ:SIBN - Nasdaq - US8257041090 - Common Stock - Currency: USD

17.2  -1.58 (-8.41%)

After market: 17.2 0 (0%)

Fundamental Rating

3

Overall SIBN gets a fundamental rating of 3 out of 10. We evaluated SIBN against 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of SIBN is average, but there are quite some concerns on its profitability. While showing a medium growth rate, SIBN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SIBN had negative earnings in the past year.
In the past year SIBN has reported a negative cash flow from operations.
SIBN had negative earnings in each of the past 5 years.
SIBN had a negative operating cash flow in each of the past 5 years.
SIBN Yearly Net Income VS EBIT VS OCF VS FCFSIBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

SIBN has a better Return On Assets (-11.68%) than 60.43% of its industry peers.
With a decent Return On Equity value of -15.87%, SIBN is doing good in the industry, outperforming 64.17% of the companies in the same industry.
Industry RankSector Rank
ROA -11.68%
ROE -15.87%
ROIC N/A
ROA(3y)-23.71%
ROA(5y)-24.08%
ROE(3y)-35.49%
ROE(5y)-34.87%
ROIC(3y)N/A
ROIC(5y)N/A
SIBN Yearly ROA, ROE, ROICSIBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

SIBN's Gross Margin of 79.25% is amongst the best of the industry. SIBN outperforms 92.51% of its industry peers.
SIBN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SIBN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.65%
GM growth 5Y-2.54%
SIBN Yearly Profit, Operating, Gross MarginsSIBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

6

2. Health

2.1 Basic Checks

SIBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
SIBN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SIBN has more shares outstanding
SIBN has a better debt/assets ratio than last year.
SIBN Yearly Shares OutstandingSIBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SIBN Yearly Total Debt VS Total AssetsSIBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 5.91 indicates that SIBN is not in any danger for bankruptcy at the moment.
SIBN has a better Altman-Z score (5.91) than 80.21% of its industry peers.
SIBN has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
SIBN's Debt to Equity ratio of 0.21 is in line compared to the rest of the industry. SIBN outperforms 52.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 5.91
ROIC/WACCN/A
WACC8.99%
SIBN Yearly LT Debt VS Equity VS FCFSIBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 8.53 indicates that SIBN has no problem at all paying its short term obligations.
With an excellent Current ratio value of 8.53, SIBN belongs to the best of the industry, outperforming 89.30% of the companies in the same industry.
SIBN has a Quick Ratio of 7.26. This indicates that SIBN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SIBN (7.26) is better than 88.77% of its industry peers.
Industry RankSector Rank
Current Ratio 8.53
Quick Ratio 7.26
SIBN Yearly Current Assets VS Current LiabilitesSIBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

SIBN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.28%, which is quite impressive.
The Revenue has grown by 22.60% in the past year. This is a very strong growth!
Measured over the past years, SIBN shows a quite strong growth in Revenue. The Revenue has been growing by 19.96% on average per year.
EPS 1Y (TTM)41.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.44%
Revenue 1Y (TTM)22.6%
Revenue growth 3Y22.84%
Revenue growth 5Y19.96%
Sales Q2Q%24.88%

3.2 Future

Based on estimates for the next years, SIBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.79% on average per year.
Based on estimates for the next years, SIBN will show a quite strong growth in Revenue. The Revenue will grow by 15.99% on average per year.
EPS Next Y15.02%
EPS Next 2Y16.07%
EPS Next 3Y14.79%
EPS Next 5YN/A
Revenue Next Year17.83%
Revenue Next 2Y17.35%
Revenue Next 3Y15.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SIBN Yearly Revenue VS EstimatesSIBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
SIBN Yearly EPS VS EstimatesSIBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SIBN. In the last year negative earnings were reported.
Also next year SIBN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SIBN Price Earnings VS Forward Price EarningsSIBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SIBN Per share dataSIBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as SIBN's earnings are expected to grow with 14.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.07%
EPS Next 3Y14.79%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SIBN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SI-BONE INC

NASDAQ:SIBN (7/11/2025, 8:00:02 PM)

After market: 17.2 0 (0%)

17.2

-1.58 (-8.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners88.88%
Inst Owner Change0%
Ins Owners3.05%
Ins Owner Change-3.61%
Market Cap732.89M
Analysts84
Price Target25.16 (46.28%)
Short Float %4.59%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.43%
Min EPS beat(2)26.02%
Max EPS beat(2)34.83%
EPS beat(4)4
Avg EPS beat(4)29.31%
Min EPS beat(4)22.01%
Max EPS beat(4)34.83%
EPS beat(8)8
Avg EPS beat(8)23.92%
EPS beat(12)11
Avg EPS beat(12)20.28%
EPS beat(16)11
Avg EPS beat(16)12.3%
Revenue beat(2)2
Avg Revenue beat(2)1.48%
Min Revenue beat(2)0.32%
Max Revenue beat(2)2.63%
Revenue beat(4)3
Avg Revenue beat(4)0.72%
Min Revenue beat(4)-2.34%
Max Revenue beat(4)2.63%
Revenue beat(8)7
Avg Revenue beat(8)1.69%
Revenue beat(12)9
Avg Revenue beat(12)1.77%
Revenue beat(16)11
Avg Revenue beat(16)1.14%
PT rev (1m)0%
PT rev (3m)0.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.33%
EPS NY rev (1m)0%
EPS NY rev (3m)7.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.15
P/FCF N/A
P/OCF N/A
P/B 4.38
P/tB 4.38
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS4.14
BVpS3.93
TBVpS3.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.68%
ROE -15.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.25%
FCFM N/A
ROA(3y)-23.71%
ROA(5y)-24.08%
ROE(3y)-35.49%
ROE(5y)-34.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.65%
GM growth 5Y-2.54%
F-Score5
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 229.58%
Cap/Sales 5.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.53
Quick Ratio 7.26
Altman-Z 5.91
F-Score5
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)219.68%
Cap/Depr(5y)238.27%
Cap/Sales(3y)6.94%
Cap/Sales(5y)6.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.44%
EPS Next Y15.02%
EPS Next 2Y16.07%
EPS Next 3Y14.79%
EPS Next 5YN/A
Revenue 1Y (TTM)22.6%
Revenue growth 3Y22.84%
Revenue growth 5Y19.96%
Sales Q2Q%24.88%
Revenue Next Year17.83%
Revenue Next 2Y17.35%
Revenue Next 3Y15.99%
Revenue Next 5YN/A
EBIT growth 1Y35.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.89%
EBIT Next 3Y31.64%
EBIT Next 5YN/A
FCF growth 1Y58.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.9%
OCF growth 3YN/A
OCF growth 5YN/A